United Kingdom · Question · Written question
UIN 377
Abiraterone
Original
Introduced
7 November 2023
Last action
9 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 November 2023
Summary
To ask the Secretary of State for Health and Social Care, if he will review the decision to reject the use of the drug Abiraterone to tackle prostate cancer.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 November 2023
Written question
To ask the Secretary of State for Health and Social Care, if he will review the decision to reject the use of the drug Abiraterone to tackle prostate cancer.
Source: Commons
9 November 2023
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body that guides the National Health Service on funding new medicines, based on clinical and cost-effectiveness.. The NHS is legally required to fund medicines recommended by ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-07/377
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1668018
- uk · wq-1668018 · source updated 9 November 2023